These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20411383)

  • 1. Three pathways for human kidney stone formation.
    Coe FL; Evan AP; Worcester EM; Lingeman JE
    Urol Res; 2010 Jun; 38(3):147-60. PubMed ID: 20411383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone.
    Evan AP; Lingeman JE; Coe FL; Worcester EM
    Semin Nephrol; 2008 Mar; 28(2):111-9. PubMed ID: 18359392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease.
    Evan AP; Lingeman JE; Worcester EM; Bledsoe SB; Sommer AJ; Williams JC; Krambeck AE; Philips CL; Coe FL
    Kidney Int; 2010 Aug; 78(3):310-7. PubMed ID: 20428098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on the pathology of kidney stone formation.
    Evan AP; Coe FL; Lingeman JE; Worcester E
    Urol Res; 2005 Nov; 33(5):383-9. PubMed ID: 16078085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of renal papillae in kidney stone formers.
    Marien TP; Miller NL
    Minerva Urol Nefrol; 2016 Dec; 68(6):496-515. PubMed ID: 27441596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones.
    Evan AP; Lingeman JE; Worcester EM; Sommer AJ; Phillips CL; Williams JC; Coe FL
    Anat Rec (Hoboken); 2014 Apr; 297(4):731-48. PubMed ID: 24478243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization.
    Evan AP; Coe FL; Rittling SR; Bledsoe SM; Shao Y; Lingeman JE; Worcester EM
    Kidney Int; 2005 Jul; 68(1):145-54. PubMed ID: 15954903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiopathology and etiology of stone formation in the kidney and the urinary tract.
    Evan AP
    Pediatr Nephrol; 2010 May; 25(5):831-41. PubMed ID: 19198886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal models of kidney stone formation: an analysis.
    Khan SR
    World J Urol; 1997; 15(4):236-43. PubMed ID: 9280052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.
    Evan A; Lingeman J; Coe FL; Worcester E
    Kidney Int; 2006 Apr; 69(8):1313-8. PubMed ID: 16614720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology-based treatment of idiopathic calcium kidney stones.
    Coe FL; Evan A; Worcester E
    Clin J Am Soc Nephrol; 2011 Aug; 6(8):2083-92. PubMed ID: 21825103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice.
    Evan AP; Weinman EJ; Wu XR; Lingeman JE; Worcester EM; Coe FL
    Urol Res; 2010 Dec; 38(6):439-52. PubMed ID: 21063698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.
    Khan SR
    J Urol; 2013 Mar; 189(3):803-11. PubMed ID: 23022011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney stone formers have more renal parenchymal crystals than non-stone formers, particularly in the papilla region.
    Okada A; Hamamoto S; Taguchi K; Unno R; Sugino T; Ando R; Mizuno K; Tozawa K; Kohri K; Yasui T
    BMC Urol; 2018 Mar; 18(1):19. PubMed ID: 29530009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease.
    Bhojani N; Paonessa JE; Hameed TA; Worcester EM; Evan AP; Coe FL; Borofsky MS; Lingeman JE
    J Urol; 2015 Nov; 194(5):1308-12. PubMed ID: 25988516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Randall's plaques in the pathogenesis of calcium stones.
    Matlaga BR; Coe FL; Evan AP; Lingeman JE
    J Urol; 2007 Jan; 177(1):31-8. PubMed ID: 17161996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.